The National Medical Products Administration (NMPA) has released the 90th batch of reference drugs for generic quality consistency evaluation (GQCE) work. This batch involves a total of 51 specifications.
Details of the Release
The 90th batch includes 42 new specifications and 9 specifications with modifications. This release is part of the ongoing efforts to ensure the quality and consistency of generic drugs in the market.
Purpose and Impact
The inclusion of these reference drugs aims to provide a standard for generic drug manufacturers to compare their products against. This helps in maintaining the efficacy and safety of generic drugs, ensuring that they meet the required regulatory standards.-Fineline Info & Tech
